StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.51−0.01 (-1.56%)

Close on Nov 18, 2026Market cap $14.02MP/E –Yield –

Citius Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Citius Pharmaceuticals

Citius Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Citius Pharmaceuticals figures

See a number that looks wrong?